About Pfizer Ophthalmics
Pfizer Ophthalmics, a division of Pfizer Inc, is committed to preserving sight and eliminating preventable blindness. Pfizer Ophthalmics discovers, develops and provides leading treatments in ophthalmology to support patients who are at risk of blindness or suffering from vision impairment, and to serve the health care professionals who treat them.
(1). World Health Organization. Bulletin of the World Health Organization. In Focus, Nov. 1 2004
(2). Congdon NG, Friedman DS, Lietman T. Important Causes of Visual Impairment in the World Today. JAMA. 2003; 290: 2057-2060.
(3). Quigley HA, Broman AT. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol 2006; 90: 262-267
(4). Lee PP, Walt JG, Doyle JJ et al. A multicenter, retrospective pilot study of resource use and costs associated with severity of disease in glaucoma. Arch Ophthalmol 2006; 124(1): 12-19
(5). The Glaucoma Foundation. Who's At Risk? Available at: http://www.glaucomafoundation.org/Risk.htm. Accessed on August 24, 2007.
(6). U.S. Food and Drug Administration. Guarding Against Glaucoma. Available at: http://www.fda.gov/fdac/features/995_glaucoma.html. Accessed on August 24, 2007.
(7). The Glaucoma Foundation. About Glaucoma. Available at: http://www.glaucomafoundation.org/about_glaucoma.htm. Accessed on August 24, 2007.
(8). Distelhorts JS, Hughes GM. Open angle glaucoma. American Family
|SOURCE All Eyes on Glaucoma(TM) Campaign|
Copyright©2007 PR Newswire.
All rights reserved